{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:20:15Z","timestamp":1793974815407,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ijcard.2014.07.103","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T19:18:13Z","timestamp":1406920693000},"page":"315-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["A systematic review of clozapine induced cardiomyopathy"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8784-1512","authenticated-orcid":false,"given":"Mohammed","family":"Alawami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Wasywich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Cicovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kenedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.07.103_bb0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0920-9964(99)00154-1","article-title":"Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life","volume":"43","author":"Voruganti","year":"2000","journal-title":"Schizophr Res"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatmentresistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl. 9","key":"10.1016\/j.ijcard.2014.07.103_bb0015","first-page":"35","article-title":"Treatment-resistant schizophrenic patients","volume":"57","author":"Kane","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/schbul\/sbj067","article-title":"Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsy-chotic drugs in resistant schizophrenia","volume":"32","author":"Lewis","year":"2006","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.schres.2004.05.015","article-title":"Suicidal risk during treatment with clozapine: a meta-analysis","volume":"73","author":"Hennen","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00001648-199710000-00010","article-title":"Mortality in current and former users of clozapine","volume":"8","author":"Walker","year":"1997","journal-title":"Epidemiology"},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2014.07.103_bb0035","first-page":"44","article-title":"Optimizing treatment with clozapine","volume":"59","author":"Conley","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0040","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archpsyc.63.6.622","article-title":"Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Krakowski","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1016\/j.ijcard.2014.07.103_bb0045","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/0269881108093588","article-title":"Outcomes for schizophrenia patients with clozapine treatment: how good does it get?","volume":"23","author":"Wheeler","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0050","article-title":"11-Year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"11","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0055","doi-asserted-by":"crossref","DOI":"10.1345\/aph.1K662","article-title":"Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand","volume":"42","author":"Wheeler","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0060","series-title":"Canadian Psychiatric Association 56th Annual Conference","article-title":"Utilization of Clozapine in Nova Scotia 1990\u20132004","author":"Libbus","year":"2006"},{"issue":"no. 6","key":"10.1016\/j.ijcard.2014.07.103_bb0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/106002809603000606","article-title":"Cardiomyopathy associated with clozapine","volume":"30","author":"Leo","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0070","series-title":"Association of Clozaril (clozapine) with cardiovascular toxicity","author":"Fontana","year":"2002"},{"issue":"6","key":"10.1016\/j.ijcard.2014.07.103_bb0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/cap.2010.2062","article-title":"Adolescent with treatment-refractory schizophrenia and clozapine induced cardiomyopathy managed with high dose olanzapine","volume":"20","author":"Bobb","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"11\u201312","key":"10.1016\/j.ijcard.2014.07.103_bb0080","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/j.1440-1614.2004.01481.x","article-title":"Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service","volume":"38","author":"Reinders","year":"2004","journal-title":"Aust N Z J Psychiatry"},{"issue":"7\u20138","key":"10.1016\/j.ijcard.2014.07.103_bb0085","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1345\/aph.16185","article-title":"Sudden cardiac death with clozapine and sertraline combination","volume":"35","author":"Hoehns","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-859X-4-10","article-title":"N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatment","volume":"4","author":"Kropp","year":"2005","journal-title":"Ann Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.ijcard.2014.07.103_bb0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJM200107193450317","article-title":"Myocarditis and cardiomyopathy associated with clozapine use in the United States","volume":"345","author":"La Grenade","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijcard.2014.07.103_bb0100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/187152512800388876","article-title":"Does a subclinical cardiotoxic effect of clozapine exist? Results from a follow-up pilot study","volume":"10","author":"Rostagno","year":"2012","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"1","key":"10.1016\/j.ijcard.2014.07.103_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S1742646407001021","article-title":"Clozapine related cardiomyopathy","volume":"3","author":"Khokhar","year":"2007","journal-title":"J Psychiatr Intensive Care"},{"issue":"3","key":"10.1016\/j.ijcard.2014.07.103_bb0110","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1039856213475684","article-title":"Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience","volume":"21","author":"Murch","year":"2013","journal-title":"Australas Psychiatry"},{"issue":"9193","key":"10.1016\/j.ijcard.2014.07.103_bb0115","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Kilian","year":"1999","journal-title":"Lancet"},{"issue":"Suppl. O","key":"10.1016\/j.ijcard.2014.07.103_bb0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/eurheartj\/16.suppl_O.36","article-title":"The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy","volume":"16","author":"Friman","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0125","first-page":"9","article-title":"Myocarditis with antipsychotics: recent cases with clozapine (Clozaril)","volume":"19","author":"Committee on Safety of Medicines","year":"1993","journal-title":"Curr Probl Pharmacov"},{"issue":"3","key":"10.1016\/j.ijcard.2014.07.103_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2125.2009.03596.x","article-title":"Drugs and dilated cardiomyopathies: a case\/noncase study in the French PharmacoVigilance Database","volume":"69","author":"Montastruc","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ijcard.2014.07.103_bb0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1176\/appi.psy.43.3.248","article-title":"Clozapine-associated cardiomyopathy","volume":"43","author":"Phan","year":"2002","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.ijcard.2014.07.103_bb0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.ijcard.2014.07.103_bb0145","first-page":"10","article-title":"Clozapine and achy breaky hearts","volume":"29","author":"New Zealand Medicines and Medical Devices Safety Authority","year":"2008","journal-title":"Prescr Update"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.jcp.0000150217.51433.9f","article-title":"Adverse cardiac effects associated with clozapine","volume":"25","author":"Merrill","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2710.2004.00616_1.x","article-title":"Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine","volume":"30","author":"Wehmeier","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2125.2003.01773.x","article-title":"Low blood selenium concentrations in schizophrenic patients on clozapine","volume":"55","author":"Vaddadi","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0165","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1152\/jappl.1999.87.4.1272","article-title":"Ozone-induced hyperresponsiveness and blockade of M2 muscarinic receptors by eosinophil major basic protein","volume":"87","author":"Yost","year":"1999","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/106002809703100206","article-title":"Lactic acidosis and fatal myocardial failure due to clozapine","volume":"31","author":"Koren","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00004714-200102000-00003","article-title":"Effects of newer atypical antipsychotics on autonomic neurocardiac function. A comparison between amisulpride, olanzapine, sertindole, and clozapine","volume":"21","author":"Agelink","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0180","unstructured":"Personal communication with Andrew Muir, Auckland University."},{"issue":"2\u20133","key":"10.1016\/j.ijcard.2014.07.103_bb0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2011.10.014","article-title":"When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature","volume":"134","author":"Manu","year":"2012","journal-title":"Schizophr Res"},{"issue":"8","key":"10.1016\/j.ijcard.2014.07.103_bb0190","first-page":"747","article-title":"Successful re-challenge with clozapine following development of clozapine-induced cardiomyopathy","volume":"42","author":"Floreani","year":"2008","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"10.1016\/j.ijcard.2014.07.103_bb0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1037\/1064-1297.14.1.94","article-title":"Cardiomyopathy associated with clozapine","volume":"14","author":"Roh","year":"2006","journal-title":"Exp Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.ijcard.2014.07.103_bb0205","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.12r08064","article-title":"Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?","volume":"74","author":"Nielsen","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.ijcard.2014.07.103_bb0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11739-010-0468-4","article-title":"Clozapine associated cardiomyopathy: a cluster of 3 cases","volume":"6","author":"Rostagno","year":"2011","journal-title":"Intern Emerg Med Jun"},{"issue":"2","key":"10.1016\/j.ijcard.2014.07.103_bb0215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ajp.2012.12060778","article-title":"Clozapine's role in the treatment of first-episode schizophrenia","volume":"170","author":"Remington","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"35","key":"10.1016\/j.ijcard.2014.07.103_bb0220","first-page":"1697","article-title":"Cardiomyopathy during clozapine therapy","volume":"145","author":"De Knijff","year":"2001","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"933","key":"10.1016\/j.ijcard.2014.07.103_bb0225","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/pmj.79.933.412","article-title":"Clozapine associated dilated cardiomyopathy","volume":"79","author":"Tanner","year":"2003","journal-title":"Postgrad Med J"},{"issue":"3","key":"10.1016\/j.ijcard.2014.07.103_bb0230","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.pra.0000320119.68928.68","article-title":"Clozapine-induced cardiomyopathy presenting as panic attacks","volume":"14","author":"Sagar","year":"2008","journal-title":"J Psychiatry Pract"},{"issue":"1","key":"10.1016\/j.ijcard.2014.07.103_bb0235","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3122\/jabfm.2008.01.070091","article-title":"Masked clozapine induced cardiomyopathy","volume":"21","author":"Charles","year":"2008","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0240","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0447.1985.tb01268.x","article-title":"Tolerability and therapeutic effect of clozapine: a retrospective investigation of 216 patients treated with clozapine for up to 12years","volume":"71","author":"Povlsen","year":"1985","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.09.2008.0958","article-title":"Antipsychotic-drug-induced dilated cardiomyopathy","author":"Taneja","year":"2009","journal-title":"BMJ Case Rep"},{"issue":"2\u20133","key":"10.1016\/j.ijcard.2014.07.103_bb0250","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.schres.2013.08.032","article-title":"Clozapine-induced cardiomyopathy: a first case in Japan","volume":"150","author":"Kikuchi","year":"2013","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.ijcard.2014.07.103_bb0260","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1039856212465777","article-title":"Monitoring of long-term cardiac complications in patients receiving clozapine","volume":"21","author":"Kidd","year":"2013","journal-title":"Australas Psychiatry"},{"key":"10.1016\/j.ijcard.2014.07.103_bb0265","first-page":"286","article-title":"Clozapine and cardiomyopathy. An investigation conducted in a Mental Health Service","volume":"16","author":"Domenichetti","year":"2010","journal-title":"Giorn Ital Psicopat"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314013138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314013138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T09:35:13Z","timestamp":1565688913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314013138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0167527314013138"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.07.103","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of clozapine induced cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.07.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}